Davenport & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.84M | Sell |
|
|||||
|
2025
Q2 | $6.09M | Sell |
|
|||||
|
2025
Q1 | $7.24M | Buy |
|
|||||
|
2024
Q4 | $8.41M | Buy |
|
|||||
|
2024
Q3 | $6.63M | Sell |
|
|||||
|
2024
Q2 | $6.06M | Buy |
|
|||||
|
2024
Q1 | $4.82M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $116K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $117K | Sell |
|
|||||
|
2021
Q2 | $126K | Hold |
|
|||||
|
2021
Q1 | $146K | Buy |
|
|||||
|
2020
Q4 | $101K | Sell |
|
|||||
|
2020
Q3 | $119K | Sell |
|
|||||
|
2020
Q2 | $186K | Buy |
|
|||||
|
2020
Q1 | $108K | Sell |
|
|||||
|
2019
Q4 | $123K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $203K | Sell |
|
|||||
|
2017
Q2 | $857K | Sell |
|
|||||
|
2017
Q1 | $941K | Buy |
|
|||||
|
2016
Q4 | $938K | Sell |
|
|||||
|
2016
Q3 | $1.5M | Sell |
|
|||||
|
2016
Q2 | $1.67M | Sell |
|
|||||
|
2016
Q1 | $1.92M | Sell |
|
|||||
|
2015
Q4 | $46.5M | Buy |
|
|||||
|
2015
Q3 | $39.3M | Buy |
|
|||||
|
2015
Q2 | $41.1M | Buy |
|
|||||
|
2015
Q1 | $42.8M | Buy |
|
|||||
|
2014
Q4 | $38.5M | Sell |
|
|||||
|
2014
Q3 | $36.6M | Buy |
|
|||||
|
2014
Q2 | $35.3M | Sell |
|
|||||
|
2014
Q1 | $62.2M | Buy |
|
|||||
|
2013
Q4 | $46.2M | Buy |
|
|||||
|
2013
Q3 | $25.3M | Buy |
|
|||||
|
2013
Q2 | $1.8M | Buy |
|